Butterfly Network (FRA:7JA) Research & Development: €30.83 Mil (TTM As of Mar. 2026)


FRA:7JA Butterfly Network Inc FRA:7JA
40 GF Score
Price €7.18
GF Value €2.00
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Butterfly Network Research & Development?

Butterfly Network FRA:7JA +1.63% 40 Research & Development is €30.83 Mil as of Mar. 2026. GuruFocus rates FRA:7JA with a GF Score™ of 40/100 and a GF Value™ of €2.00 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Butterfly Network's Research & Development for the three months ended in Mar. 2026 was €8.25 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €30.83 Mil.

Butterfly Network  (FRA:7JA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Butterfly Network Research & Development Related Terms

Butterfly Network Research & Development Historical Data

* Premium members only.

The historical data trend for Butterfly Network's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Butterfly Network Research & Development Chart

Butterfly Network Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 65.90 83.11 51.00 36.10 30.97

Butterfly Network Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.18 7.21 7.42 7.96 8.25
FRA:7JA
40GF Score
Butterfly Network Inc FRA:7JA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Butterfly Network Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €30.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €30.83 Mil mean?
Butterfly Network (FRA:7JA) has a Research & Development of €30.83 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Butterfly Network and its competitors.
Is Butterfly Network's Research & Development too high?
Butterfly Network's current Research & Development is €30.83 Mil. Overall, Butterfly Network has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's Research & Development compare to TMDX and AXGN?
Butterfly Network's Research & Development of €30.83 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Butterfly Network and its competitors. Butterfly Network's current Research & Development is €30.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (FRA:7JA) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.00, compared to a current price of €7.18 — trading 259% above its estimated fair value. The current Research & Development is €30.83 Mil. Butterfly Network's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Butterfly Network (FRA:7JA), the current Research & Development is €30.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Butterfly Network (FRA:7JA) Overvalued in 2026?

Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued. The current stock price of €7.18 is trading 259% above its estimated GF Value™ of €2.00. GuruFocus considers Butterfly Network to be Significantly Overvalued.

Key valuation signals for FRA:7JA:

  • Research & Development: €30.83 Mil
  • GF Value™: €2.00 vs. price of €7.18 (259% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:7JA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Butterfly Network Business Description

Other Exchanges BFLY:USA
Address 1600 District Avenue, Burlington, MA, USA, 01803
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
40GF Score

Get the complete analysis for FRA:7JA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.18
Price
€2.00
GF Value